Across North America, the expanding use of duloxetine formulations and the presence of an established pharmaceutical industry are supporting demand for active pharmaceutical ingredients. Growing generic drug production, increasing focus on cost-effective healthcare solutions, and ongoing investments in pharmaceutical manufacturing capabilities are creating favorable opportunities for API...